Reaction
Acrochordon reporting signals
As of the last recalculation, Acrochordon appears in 1,303 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is VEMURAFENIB (PRR 66.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vemurafenib | 48 | 66.2 | 66.5 |
| Encorafenib | 17 | 27.8 | 27.8 |
| Dabrafenib | 20 | 15.4 | 15.4 |
| Infliximab-Dyyb | 21 | 11.6 | 11.7 |
| Teduglutide | 8 | 9.5 | 9.5 |
| Siponimod | 5 | 9.0 | 9.0 |
| Avapritinib | 6 | 7.9 | 8.0 |
| Fingolimod Hcl | 41 | 7.8 | 7.8 |
| Trametinib | 10 | 6.7 | 6.7 |
| Risankizumab-Rzaa | 33 | 6.6 | 6.6 |
| Lanreotide Acetate | 3 | 6.1 | 6.1 |
| Acalabrutinib | 4 | 5.3 | 5.3 |
| Peginterferon Beta-1A | 4 | 4.9 | 4.9 |
| Dofetilide | 3 | 4.6 | 4.6 |
| Lifitegrast | 3 | 2.9 | 2.9 |
| Relugolix | 4 | 2.7 | 2.7 |
| Minoxidil Foam 5% (Womens) | 5 | 2.4 | 2.4 |
| Minoxidil | 6 | 2.1 | 2.1 |
| Copper | 3 | 1.1 | 1.1 |